Back to results
US 4,309,431 AGranted
Method of inhibiting growth of tumor cells
AssigneeEli Lilly and Company
InventorGordon H. Svoboda
Life of this patent
Estimating the term…
Abstract
This invention relates to a novel process for inhibiting the growth of malignant tumor cells in mammals, particularly the growth of multiple myeloma in humans, employing the alkaloid acronycine as the inhibiting agent.
Claims4
A method of treating multiple myeloma in humans which comprises administering acronycine to a patient suffering therefrom in an oncolytic amount.
A pharmaceutical preparation in dosage unit form adapted for oral administration to achieve an anti-tumor effect in multiple myeloma comprising per dosage unit from 15-100 mgs. of acronycine and from 0.165 to 0.3 g. of starch.
Dependencies are inferred from the claim text.